Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Clinical trial NCT01240629 · COMPLETED
Trial details
- NCT number
- NCT01240629
- Sponsor
- University of Southern California
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-02
- Primary completion
- 2017-02-02
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.